Belpointe PREP 3Q 2026: Revenue $6.3M, Net loss $8.7M — 10-Q Summary

Belpointe PREP reported Q3 2026 revenue of $6.3M, up 165.6% YoY, and a net loss of $8.7M, narrowed from $12.1M. Loss per Class A unit was $2.20. Properties Aster & Links and VIV were 92% and 86% leased, respectively. Nine-month rental revenue increased to $15.9M. The company plans to sell Davidson Properties and pursue multifamily projects.

Original reporting
Published Nov 4, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Belpointe PREP 3Q 2026: Revenue $6.3M, Net loss $8.7M — 10-Q Summary — source image
Decision brief

The 30-second read

Low
01

Why it matters

Impact Analysis

02

Market read

The filing provides the first public numbers for Belpointe PREP, but its micro‑cap size limits broader market relevance.

03

What to watch

Potential dilution from future capital raises and reliance on a few key properties.

Relevance 6/10Novelty 6/10Timing: post-market today

Background

Belpointe PREP filed its 10‑Q for Q3 2026, showing a sharp revenue increase and narrowed loss.

Market effects

Minimal impact on the broader REIT sector due to small size.

Limited to niche multifamily/mixed‑use property investors.

None

Counterpoint

The revenue surge may be temporary; underlying lease occupancy risks remain.

Key entities

  • Belpointe PREP

    Private real‑estate investment trust reporting Q3 2026 results.

Related articles

$ZTEKFMed

Zentek Ltd. (ZTEKF): Financial results for FY2027

Zentek Ltd. (ZTEKF) furnished an SEC Form 6-K — earnings release. Zentek Q2 Fiscal 2027 Results News Release Zentek Strengthens Its Balance Sheet, Ends Second Quarter with $13.6 Million in Cash Working capital of $11.3 million at September 30, 2026, compared with a deficit of $1.3 million at March 31, 2026 Guelph, Ontario, November 16, 2026. Ze

$WBMedAI 8/10

Alibaba Is Pulling Back From This 10% Dividend Stock

Weibo (WB) missed Q3 revenue and earnings expectations, with advertising revenue from Alibaba (BABA) falling 33%. Shares dropped 4% premarket. GAAP net income fell 88.91%, operating cash flow turned negative, and long-term loans were reclassified as current. The dividend yield is 10.6%, but earnings are declining. CEO Gaofei Wang highlighted AI efforts, but ad budgets remain a concern.

$SLSHighAI 9/10

SELLAS Gets A REGAL Boost As Immunotherapeutic Cancer Vaccine Trial Meets Primary Endpoint

SELLAS Life Sciences (SLS) reported positive Phase 3 REGAL trial results for its cancer vaccine, Galinpepimut-S (GPS), meeting the primary endpoint of overall survival. GPS reduced the risk of death by 41% compared to standard treatment, with median OS of 24.0 months vs. 14.7 months. The company plans to discuss an accelerated FDA filing pathway and aims for a BLA submission in early 2027. Shares surged over 255% in premarket trading.

$RIMEMed

Algorhythm Holdings Reports Third Quarter 2026 Financial Results

Algorhythm Holdings, Inc. (RIME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Algorhythm Holdings Reports Third Quarter 2026 Financial Results Company Completes Azure Energy Acquisition and Begins Strategic Restructuring Fort Lauderdale, FL, November 17, 2026 – Algorhythm Holdings, Inc. (the “Company”) (NASDAQ: RIME ), a diversified holding co